Back to Work After Bariatric Surgery? A Belgian Population Study.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
08 2022
Historique:
received: 21 02 2022
accepted: 24 05 2022
revised: 13 05 2022
pubmed: 16 6 2022
medline: 14 7 2022
entrez: 15 6 2022
Statut: ppublish

Résumé

Aside from an impact on health, obesity is also associated with higher social and economic costs such as impaired productivity, increased work absenteeism, and higher rates of unemployment. The aim of this study was to assess the effect of bariatric surgery on employment status in a large nationwide database, using data from all patients that underwent bariatric surgery in Belgium. This is a retrospective analysis of all Belgian patients that underwent bariatric surgery between 2014 and 2015. The work status of these patients was examined yearly: 4 years before and 3 years after surgery. Increased employment after surgery was defined (1) as a reduction in days of unemployment and incapacity and (2) as the resumption of work among the unemployed. In total, 16,276 patients were included. The number of working people rose from 49.7% before to 61.2% 3 years after bariatric surgery, i.e., an increase of 11.5% between pre- and post-surgery. The largest improvement in reduction in unemployment was found in individuals who were absent from work for more than 9 months, namely, a reduction from 13.4 to 7.2%. In the population of unemployed patients, 20.9% became employed after bariatric surgery. We found an increase in employment rate and a decrease in work incapacity and unemployment after bariatric surgery. Higher rates of employment after bariatric surgery may also contribute to an increased cost-effectiveness of bariatric surgery. It would be interesting to research possible targeting strategies to increase the employment rate even more after bariatric surgery.

Identifiants

pubmed: 35705782
doi: 10.1007/s11695-022-06118-5
pii: 10.1007/s11695-022-06118-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2625-2631

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011;377(9765):557–67. https://doi.org/10.1016/S0140-6736(10)62037-5
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL. The global obesity pandemic: shaped by global drivers and local environments. Lancet. 2011;378(9793):804–14. https://doi.org/10.1016/S0140-6736(11)60813-1 .
doi: 10.1016/S0140-6736(11)60813-1 pubmed: 21872749
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1–253
Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L; NEDCOM, the Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138(1):24–32. https://doi.org/10.7326/0003-4819-138-1-200301070-00008
Haslam DW, James WP. Obesity Lancet. 2005;366(9492):1197–209. https://doi.org/10.1016/S0140-6736(05)67483-1 .
doi: 10.1016/S0140-6736(05)67483-1 pubmed: 16198769
McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities. Ann N Y Acad Sci. 2018;1411(1):96–105. https://doi.org/10.1111/nyas.13467 .
doi: 10.1111/nyas.13467 pubmed: 29044551
Klarenbach S, Padwal R, Chuck A, Jacobs P. Population-based analysis of obesity and workforce participation. Obesity (Silver Spring). 2006;14(5):920–7. https://doi.org/10.1038/oby.2006.106 .
doi: 10.1038/oby.2006.106
Jusot F, Khlat M, Rochereau T, Serme C. Job loss from poor health, smoking and obesity: a national prospective survey in France. J Epidemiol Community Health. 2008;62(4):332–7. https://doi.org/10.1136/jech.2007.060772 .
doi: 10.1136/jech.2007.060772 pubmed: 18339826
Sharples AJ, Cheruvu CV. Systematic review and meta-analysis of occupational outcomes after bariatric surgery. Obes Surg. 2017;27(3):774–81. https://doi.org/10.1007/s11695-016-2367-x .
doi: 10.1007/s11695-016-2367-x pubmed: 27605376
Harvey SB, Glozier N, Carlton O, Mykletun A, Henderson M, Hotopf M, Holland-Elliott K. Obesity and sickness absence: results from the CHAP study. Occup Med (Lond). 2010;60(5):362–8. https://doi.org/10.1093/occmed/kqq031 .
doi: 10.1093/occmed/kqq031
Neovius K, Johansson K, Rössner S, Neovius M. Disability pension, employment and obesity status: a systematic review. Obes Rev. 2008;9(6):572–81. https://doi.org/10.1111/j.1467-789X.2008.00502.x .
doi: 10.1111/j.1467-789X.2008.00502.x pubmed: 18518906
Turchiano M, Saunders JK, Fernandez G, Navie L, Labrador L, Parikh M. Bariatric surgery may improve employment status in unemployed, underserved, severely obese patients. Obes Surg. 2014;24(5):692–5. https://doi.org/10.1007/s11695-013-1140-7 .
doi: 10.1007/s11695-013-1140-7 pubmed: 24307435
Mancini A, Borel AL, Coumes S, Wion N, Arvieux C, Reche F. Bariatric surgery improves the employment rate in people with obesity: 2-year analysis. Surg Obes Relat Dis. 2018;14(11):1700–4. https://doi.org/10.1016/j.soard.2018.06.026 .
doi: 10.1016/j.soard.2018.06.026 pubmed: 30166261
Reid RER, Jirasek K, Carver TE, Reid TGR, Andersen KM, Christou NV, Andersen RE. Effect of employment status on physical activity and sedentary behavior long-term post-bariatric surgery. Obes Surg. 2018;28(3):869–73. https://doi.org/10.1007/s11695-017-3079-6 .
doi: 10.1007/s11695-017-3079-6 pubmed: 29307108
Courtney MJ, Mahawar K, Burnell P, Jennings N, Balupuri S, Schroeder N, Small P, Carr W. Occupational outcomes of obesity surgery-do the employed return to work, and do the unemployed find work? Obes Surg. 2018;28(4):963–9. https://doi.org/10.1007/s11695-017-2963-4 .
doi: 10.1007/s11695-017-2963-4 pubmed: 29101716
Cazzo E, Ramos AC, Chaim EA. Bariatric surgery offer in Brazil: a macroeconomic analysis of the health system’s inequalities. Obes Surg. 2019;29(6):1874–80. https://doi.org/10.1007/s11695-019-03761-3 .
doi: 10.1007/s11695-019-03761-3 pubmed: 30739302
Andersen JR, Hernæs UJ, Hufthammer KO, Våge V. Employment status and sick-leave following obesity surgery: a five-year prospective cohort study. PeerJ. 2015;29(3):e1285. https://doi.org/10.7717/peerj.1285 .
doi: 10.7717/peerj.1285
Louwagie P, Neyt M, Dossche D, Camberlin C, ten Geuzendam B, Van den Heede K, Van Brabandt H. Bariatric surgery: an HTA report on the efficacy, safety and cost-effectiveness. Health Technology Assessment (HTA) Brussels: Belgian Health Care Knowledge Centre (KCE). 2019. KCE Reports 316. D/2019/10.273/44.
Borisenko O, Lukyanov V, Debergh I, Dillemans B. Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium. J Med Econ. 2018;21(4):365–73. https://doi.org/10.1080/13696998.2017.1419958 .
doi: 10.1080/13696998.2017.1419958 pubmed: 29271279

Auteurs

Amber Van den Eynde (A)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium. amber.vandeneynde@uzleuven.be.
Department of Endocrinology, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium. amber.vandeneynde@uzleuven.be.

Diederik De Cock (D)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium.

Valérie Fabri (V)

IMA-AIM, VZW Intermutualistisch Agentschap, Bolwerklaan 21 B7, 1210, Brussels, Belgium.

Wies Kestens (W)

IMA-AIM, VZW Intermutualistisch Agentschap, Bolwerklaan 21 B7, 1210, Brussels, Belgium.

Tonio Di Zinno (T)

IMA-AIM, VZW Intermutualistisch Agentschap, Bolwerklaan 21 B7, 1210, Brussels, Belgium.

Steven Brabant (S)

IMA-AIM, VZW Intermutualistisch Agentschap, Bolwerklaan 21 B7, 1210, Brussels, Belgium.

Ann Mertens (A)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium.
Department of Endocrinology, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Roman Vangoitsenhoven (R)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium.
Department of Endocrinology, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Ellen Deleus (E)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium.
Department of Abdominal Surgery, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Matthias Lannoo (M)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium.
Department of Abdominal Surgery, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Ronny Bruffaerts (R)

Center for Public Health Psychiatry, University Psychiatric Center KU Leuven, UZ, Herestraat 49 - bus 7003, 3000, Louvain, Belgium.

Agnès Leclercq (A)

IMA-AIM, VZW Intermutualistisch Agentschap, Bolwerklaan 21 B7, 1210, Brussels, Belgium.

Bart Van der Schueren (B)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, ON I Herestraat 49 - bus 902, 3000, Louvain, Belgium.
Department of Endocrinology, University Hospitals Leuven, Herestraat 49, 3000, Louvain, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH